Pages that link to "Q43115659"

The following pages link to Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy (Q43115659):

Displaying 28 items.

• Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors (Q28818166) (← links)
• Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma (Q35406476) (← links)
• Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival (Q35506234) (← links)
• Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation (Q36642844) (← links)
• Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy (Q36646476) (← links)
• Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer (Q36866163) (← links)
• Cancer prevention and therapy through the modulation of the tumor microenvironment (Q37058267) (← links)
• Indoleamine 2,3-dioxygenase: is it an immune suppressor? (Q37362632) (← links)
• Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer (Q37711667) (← links)
• Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer (Q37798692) (← links)
• Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance (Q37836612) (← links)
• Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy. (Q38036688) (← links)
• Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival (Q38650706) (← links)
• Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma (Q39336624) (← links)
• The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy (Q41149149) (← links)
• Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma (Q44876069) (← links)
• The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancer (Q46579742) (← links)
• Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences. (Q48306002) (← links)
• Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis (Q48966344) (← links)
• Modulation of antigen presenting cell functions during chronic HPV infection. (Q49591682) (← links)
• The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer (Q60442132) (← links)
• Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer. (Q64923604) (← links)
• Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests (Q84203732) (← links)
• Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer (Q90176765) (← links)
• Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer (Q92617238) (← links)
• Inhibition of Indoleamine 2,3 Dioxygenase Does Not Improve Cancer-Related Symptoms in a Murine Model of Human Papilloma Virus-Related Head and Neck Cancer (Q93185054) (← links)
• Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma (Q96683512) (← links)
• IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma (Q98178317) (← links)